Apralogs: Apramycin 5-O-Glycosides and Ethers with Improved Antibacterial Activity and Ribosomal Selectivity and Reduced Susceptibility to the Aminoacyltranserferase (3)-IV Resistance Determinant.

Схожие документы

• An Advanced Apralog with Increased in-vitro and in-vivo Activity toward Gram-negative Pathogens and Reduced ex-vivo Cochleotoxicity.
  по: Sonousi, Amr, et al.
  Опубликовано: (2020)
• Synthesis of saccharocin from apramycin and evaluation of its ribosomal selectivity
  по: Sarpe, Vikram A., et al.
  Опубликовано: (2019)
• Structure-Based Design and Synthesis of Apramycin-Paromomycin Analogues. Importance of the Configuration at the 6′-Position and Differences Between the 6′-Amino and Hydroxy Series
  по: Mandhapati, Appi Reddy, et al.
  Опубликовано: (2017)
• Predictive Analysis of the Side Chain Conformation of the Higher Carbon Sugars: Application to the Preorganization of the Aminoglycoside Ring 1 Side Chain for Binding to the Bacterial Ribosomal Decoding A Site
  по: Pirrone, Michael G., et al.
  Опубликовано: (2020)
• Effects of the 1-N-(4-Amino-2S-hydroxybutyryl) and 6′-N-(2-Hydroxyethyl) Substituents on Ribosomal Selectivity, Cochleotoxicity and Antibacterial Activity in the Sisomicin Class of Aminoglycoside Antibiotics
  по: Sonousi, Amr, et al.
  Опубликовано: (2018)